Possibility of a new functional food component from soybeans
从大豆中提取新的功能性食品成分的可能性
基本信息
- 批准号:18500618
- 负责人:
- 金额:$ 2.61万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The present study was designed to investigate the effects of Bowman-Birk inhibitor concentrate(BBIC) from soybean on anti-proliferation, up-regulation of Connexin (Cx) 43 expression and inhabitation of hepatic metastasis in mice with M5076 ovarian sarcoma. M5076 ovarian sarcomas (1×10^6 cells/animal) were subcutaneously transplanted into the back of BDF_1 mice. "Pre-treated group" (n=10) and "post-treated group" (n=10) were fed with standard diet (CE-2, Crea Japan) compounded 0.5%-1% BBI from 3 weeks before and at the day of tumor inoculation until the weeks after tumor inoculation, respectively. "Control group" (n=10) was fed with CE-2 alone. The relative tumor weights in the pre- (0.013±0.010) and post- (0.012±0.013) treated groups were significantly reduced by 30.0% and 32.5% compared with that in the control group (0.040±0.022, p<0.01), respectively. The relative densities of Cx43-mRNA and Cx43 proteins in the BBIC treated groups were significantly higher than that in the control group. The median numbers of macroscopic spontaneous metastases in the pre- (1.0±2.3) and post-(1.9±3.6) treated groups were significantly lower than that in the control group (71.4±97.3), and, respectively. These results suggested that BBIC induced anti-proliferation caused by the expression of Cx43 genes in mice with M5076 ovarian sarcoma. In addition, BBIC inhibited the hepatic metastasis in M5076 bearing mice. Overall, It seems that BBI is a promising candidate to prevent the development of tumors in which Cx43 acts as a tumor suppressor gene.
本研究旨在探讨大豆Bowman-Birk抑制剂浓缩物(BBIC)对M5076卵巢肉瘤小鼠的抗增殖、上调连接蛋白(Cx) 43的表达和抑制肝转移的作用。将M5076卵巢肉瘤(1×10^6个细胞/只)皮下移植至BDF_1小鼠背部。“预处理组”(n=10)和“后处理组”(n=10)分别于肿瘤接种前3周和当日至肿瘤接种后1周,分别饲喂添加0.5% ~ 1% BBI的标准饲粮(CE-2, Crea Japan)。对照组(n=10)单独饲喂CE-2。与对照组(0.040±0.022,p<0.01)相比,治疗前(0.013±0.010)组和治疗后(0.012±0.013)组的相对肿瘤重量分别显著降低30.0%和32.5%。BBIC处理组Cx43- mrna和Cx43蛋白的相对密度显著高于对照组。治疗前(1.0±2.3)组和治疗后(1.9±3.6)组宏观自发转移中位数分别显著低于对照组(71.4±97.3)和(1.9±3.6)。上述结果表明,BBIC可诱导M5076卵巢肉瘤小鼠抗增殖,其作用机制是Cx43基因的表达。此外,BBIC还能抑制M5076荷瘤小鼠的肝转移。总的来说,BBI似乎是一个有希望的候选物,可以预防肿瘤的发展,其中Cx43作为肿瘤抑制基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A New Mechanism on Anti-carcinogenic Effect of Bowman-Birk Protease Inhibitor(BBI) from Soybeans
大豆鲍曼-伯克蛋白酶抑制剂(BBI)抗癌新机制
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yano T;Saito T;Kashiwagi K;Hagiwara H;Sato H
- 通讯作者:Sato H
Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
- DOI:10.1016/j.canlet.2007.01.021
- 发表时间:2007-08
- 期刊:
- 影响因子:9.7
- 作者:Teruyoshi Saito;Hiromi Sato;N. Virgona;H. Hagiwara;K. Kashiwagi;Kazuyuki Suzuki;R. Asano;T. Yano
- 通讯作者:Teruyoshi Saito;Hiromi Sato;N. Virgona;H. Hagiwara;K. Kashiwagi;Kazuyuki Suzuki;R. Asano;T. Yano
New Mechanism on Anti-carcinogenic Effect of Bowman-Birk Protease Inhibitor (BBI) from Soybeans
大豆鲍曼-伯克蛋白酶抑制剂(BBI)抗癌新机制
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yano T; Saito T; Kashiwagi K; Hagiwara H; Sato H
- 通讯作者:Sato H
がん抑制遺伝子(コネキシン43)の発現・機能回復による中皮腫発生抑制に関する研究-大豆由来のBowman-Birk protease inhibitorを用いた検討-
通过肿瘤抑制基因(连接蛋白43)的表达和功能恢复来抑制间皮瘤发展的研究 - 使用源自大豆的 Bowman-Birk 蛋白酶抑制剂的研究 -
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:矢野友啓;柏木維人;佐藤洋美
- 通讯作者:佐藤洋美
The effects of Bowman-Birk Protease inhibitor concentrate BBIC) on anti-proliferation and inhbition of metastasis in M5076 bearing mice.
Bowman-Birk 蛋白酶抑制剂浓缩物 BBIC) 对携带 M5076 的小鼠的抗增殖和抑制转移的作用。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Sano Y;Yoshimura H;Nishimura Y;Sakurai N;Suzuki ;Yano T
- 通讯作者:Yano T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANO Tomohiro其他文献
YANO Tomohiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YANO Tomohiro', 18)}}的其他基金
Bioavailability evaluation on a new food component from soybeans
大豆新食品成分的生物利用度评价
- 批准号:
22500754 - 财政年份:2010
- 资助金额:
$ 2.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Determination of connexin gene contributing to suppression of canine mammary carcinogenesis and investigation of the mechanism
抑制犬乳腺癌发生的连接蛋白基因的测定及其机制研究
- 批准号:
16580259 - 财政年份:2004
- 资助金额:
$ 2.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
THE ESTIMATION OF A USEFUL LEVEL OF VITAMINE INTAKE AGAINST THE PREVENTION OF LUNG ADENOCARCINOMA
估计预防肺腺癌的有效维生素摄入水平
- 批准号:
07680075 - 财政年份:1995
- 资助金额:
$ 2.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
大豆BBI 基纳米载体输送疏水性生物活性物质的机理研究
- 批准号:2019JJ40536
- 批准年份:2019
- 资助金额:0.0 万元
- 项目类别:省市级项目
胰蛋白酶抑制剂BBI通过RIP3激活线粒体途径诱导肿瘤细胞凋亡的机制研究
- 批准号:31271476
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
大豆蛋白酶抑制物BBI对食管癌的抗癌及其机理的研究
- 批准号:38970815
- 批准年份:1989
- 资助金额:3.0 万元
- 项目类别:面上项目
相似海外基金
Preparing BBI-001 as an oral, non-absorbed iron chelator for prevention of iron overload
将 BBI-001 制备为口服非吸收铁螯合剂,用于预防铁过载
- 批准号:
10258539 - 财政年份:2021
- 资助金额:
$ 2.61万 - 项目类别:
(OTHER FUNCTIONS) PRODUCE AND PUBLISH BBI JOURNAL SUPPLEMENT
(其他职能)制作和出版 BBI 期刊增刊
- 批准号:
8561749 - 财政年份:2012
- 资助金额:
$ 2.61万 - 项目类别:
プロテアーゼインヒビターBBI遺伝子によるカドミウム非吸収型作物の創出
使用蛋白酶抑制剂 BBI 基因培育不吸收镉的作物
- 批准号:
19658125 - 财政年份:2007
- 资助金额:
$ 2.61万 - 项目类别:
Grant-in-Aid for Exploratory Research














{{item.name}}会员




